Chronic Granulomatous Disease: the Experience of Diagnosis and Treatment in Children
DOI:
https://doi.org/10.22141/2224-0551.4.47.2013.89801Keywords:
chronic granulomatous disease, primary immune deficiency, childrenAbstract
Chronic granulomatous disease — primary immunodeficiency with X-linked and autosomal recessive inheritance, characterized by impaired bactericidal function of phagocytic immune system. Chronic granulomatous disease is accompanied by the development of severe bacterial and fungal infections of the skin, lymph nodes, lungs, liver, and excessive inflammation with granuloma formation. For the first time in Ukraine the paper describes cases of chronic granulomatous disease in children with a characteristic clinical phenotype in the form of severe bacterial infections with the lesion of the different organs and systems, the manifestation in the first months of life. We should note patients’ predisposition to mycobacterial infection, caused both by typical Mycobacterium tuberculosis, and atypical mycobacteria, including Mycobacterium bovis, BCG strain. Now the question of early diagnosis and optimization of treatment of chronic granulomatous disease in Ukraine remaines extremely topical.
Downloads
References
Beauté J., Obenga G., Le Mignot L. et al. Epidemiology and outcome of invasive fungal diseases in patients with chronic granulomatous disease: a multicenter study in France // Pediatr. Infect. Dis. J. — 2011. — 30(1). — 57.
Gallin J.I., Alling D.W., Malech H.L. et al. Itraconazole to prevent fungal infections in chronic granulomatous disease // N. Engl. J. Med. — 2003. — V. 348(24). — P. 2416-22
Holland S.M. Chronic granulomatous disease // Clin. Rev. Allergy Immunol. — 2010 Feb. — 38(1). — 3-10.
Jones L.B., McGrogan P., Flood T.J. et al. Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry // Clin. Exp. Immunol.— 2008. — 152. — 211.
Kuhns D.B., Alvord W.G., Heller T. et al. Residual NADPH oxidase and survival in chronic granulomatous disease // N. Engl J. Med. — 2010. – V. 36. — P. 2600.
Martire B., Rondelli R., Soresina A. et al. Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study // Clin. Immunol. — 2008. — V. 126(2). — 155-64.
Merlijn van den Berg J., van Koppen E., Åhlin A. Chronic Granulomatous Disease: The European Experience // PLoS ONE. — 2009. — 4(4). — e5234.
Rich R.R., Fleisher T.A., Shearer W.T. Clinical Immunology: Principles and Practice. — Elsevier Limited, 2008. — 1578 p.
Winkelstein J.A., Marino M.C., Johnston R.B. Chronic granulomatous disease. Report on a national registry of 368 patients // Medicine (Baltimore). — 2000. — V. 79(3). — 155-69.
Seger RA. Modern management of chronic granulomatous disease // Br. J. Haematol. — 2000. — V. 140, 255. — Р. 334-339.
Segal B.H., Veys P., Malech H. et al. Chronic granulomatous disease: Lessons from a rare disorder // Biol. Blood Marrow Transplant. — 2011 January. — 17(1 Suppl.). — S123-S131.
Stiem E.R., Ochs H.D., Winkelstein J.A. Immunologic disorders in infants and children. — 5th ed. — Elsevier Saunders, 2004. — 1512 p.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 L.I. Chernyshova, A.P. Volokha, A.V. Bondarenko, A.M. Gilfanova, V.P. Chernyshov
This work is licensed under a Creative Commons Attribution 4.0 International License.